By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company MicroPort Scientific Corporation

MicroPort Scientific Corporation (0853.HK)

HKSE Market Data in HKD, Fundamentals in USD
$14.10
+$1.99
+16.43%
Last Update: 1 Sept 2025, 05:25
$26.22B
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$4.48 - $15.56
52 Week Range

0853.HK Stock Price Chart

Explore MicroPort Scientific Corporation interactive price chart. Choose custom timeframes to analyze 0853.HK price movements and trends.

0853.HK Company Profile

Discover essential business fundamentals and corporate details for MicroPort Scientific Corporation (0853.HK) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

24 Sept 2010

Employees

6.35K

CEO

Zhaohua Chang

Description

MicroPort Scientific Corporation, an investment holding company, manufactures, and markets, and distributes medical devices in the People's Republic of China, North America, Europe, other Asian countries, South America, and internationally. The company's Cardiovascular Devices segment offers products and services for the treatment of coronary artery-related diseases; coronary stents and related delivery systems; and balloon catheters and accessories. Its Orthopedics Devices segment provides reconstructive joints, spine and trauma, and other professional implants and instruments. The company's Cardiac Rhythm Management Business segment offers defibrillators, cardiac resynchronization therapy devices, and pacemakers for the diagnosis, treatment, and management of heart rhythm disorders and heart failure. Its Endovascular and Peripheral Vascular Devices segment provides products and services for the interventional treatment of thoracic and abdominal aortic aneurysm, peripheral vascular diseases, aortic dissection, and other endovascular related diseases. The company's Neurovascular Devices segment offers neurovascular therapeutic and access devices for neurovascular diseases. Its Heart Valve Business segment provides VitaFlow Transcatheter aortic valve and delivery system, VitaFlow Liberty Transcatheter aortic valve implantation and retrievable delivery systems, Alwide Plus Balloon Catheter, various transcatheter aortic valve implantation, transcatheter mitral valve, transcatheter tricuspid valve, and surgical valve products. The company's Surgical Robot Business segment designs, develops, and commercializes surgical robots comprising robot ontology, control algorithm, electrical engineering, image-based navigation, and precision imaging. Its Surgical Devices segment researches and develops, manufactures, and sells surgical devices. MicroPort Scientific Corporation was founded in 1998 and is headquartered in Shanghai, the People's Republic of China.

0853.HK Financial Timeline

Browse a chronological timeline of MicroPort Scientific Corporation corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 26 Mar 2026

Earnings released on 29 Aug 2025

EPS came in at -$0.22 , while revenue for the quarter reached $4.30B , missing expectations by -3.94%.

Earnings released on 28 Mar 2025

EPS came in at -$0.50 , while revenue for the quarter reached $3.67B , missing expectations by -3.05%.

Earnings released on 30 Oct 2024

EPS came in at -$0.41 , while revenue for the quarter reached $4.36B .

Earnings released on 28 Mar 2024

EPS came in at -$1.34 , while revenue for the quarter reached $3.66B , missing expectations by -60.05%.

Earnings released on 31 Aug 2023

EPS came in at -$0.70 , while revenue for the quarter reached $3.78B , missing expectations by -0.54%.

Earnings released on 31 Mar 2023

EPS came in at -$1.02 , while revenue for the quarter reached $3.40B , missing expectations by -59.65%.

Earnings released on 30 Jun 2022

EPS came in at -$0.86 , while revenue for the quarter reached $3.18B , missing expectations by -6.72%.

Earnings released on 28 Mar 2022

EPS came in at -$0.80 , while revenue for the quarter reached $3.07B .

Earnings released on 30 Jun 2021

EPS came in at -$0.39 , while revenue for the quarter reached $2.99B .

Dividend declared on 28 Jun 2021

A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 18 Aug 2021.

Earnings released on 31 Dec 2020

EPS came in at -$0.53 , while revenue for the quarter reached $2.65B .

0853.HK Stock Performance

Access detailed 0853.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run